KalVista to Go Public in Reverse Merger

The Deal

"Privately held KalVista Pharmaceuticals Ltd. announced June 15 that it will acquire the struggling Palo Alto, Calif.-based biotech company in a reverse merger. The transaction concludes Carbylan's Wedbush Pacgrow Health-led strategic review, which was launched March 18."

Read the article here.

Related Contacts
Stephen Rosen Partner, London